Showing results (331-340 of 452) with videos related to

Sort By:
Pageof 46
The Journal of Clinical Investigation|November 10, 2015
Blood kinetics of Ebola virus in survivors and nonsurvivorsSimone Lanini, Gina Portella, Francesco Vairo, et al.
The American Journal of Tropical Medicine and Hygiene|November 14, 2022
Toward a New Paradigm of North-South and South-South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other OutbreaksSabin Nsanzimana, Angeli Rawat, Lindsay A Wilson, et al.
Epidemiology and Infection|January 7, 2025
The 2023 fatal dengue outbreak in Bangladesh highlights a paradigm shift of geographical distribution of casesMohammad Nayeem Hasan, Mahbubur Rahman, Meraj Uddin, et al.
The Pediatric Infectious Disease Journal|April 1, 2016
Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in ZambiaMwila Kabwe, John Tembo, Lophina Chilukutu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort StudySimone Lanini, Gina Portella, Francesco Vairo, et al.
The American Journal of Tropical Medicine and Hygiene|April 24, 2020
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare SettingsPascale M Abena, Eric H Decloedt, Emmanuel Bottieau, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 16, 2022
High genetic diversity of human rhinovirus among pilgrims with acute respiratory tract infections during the 2019 Hajj pilgrimage seasonSherif A El-Kafrawy, Salma M Alsayed, Thamir A Alandijany, et al.
The Lancet. Microbe|July 29, 2026
Advances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental prioritiesGerhard Walzl, Timothy D McHugh, Jeremiah Chakaya, et al.
Plos Pathogens|September 19, 2022
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected miceSherif A El-Kafrawy, Abby Odle, Aymn T Abbas, et al.
IJID Regions|June 20, 2022
Clinical characteristics and outcomes of confirmed COVID-19 patients in the early months of the pandemic in Tanzania: a multicenter cohort studyNicholaus P Mnyambwa, Clara Lubinza, Esther Ngadaya, et al.
Pageof 46